References
- Zheng J. SARS-CoV-2: an emerging coronavirus that causes a global threat. Int J Biol Sci. 2020;16(10):1678–85. doi:10.7150/ijbs.45053.
- Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Bio Medica. 2020;91(1):157. doi:10.23750/abm.v91i1.9397.
- Ducharme J. Time. World health organization declares COVID-19 a “Pandemic.” Here’s what that means. 2020 [accessed 2021 June 11]. https://time.com/5791661/who-coronavirus-pandemic-declaration/.
- Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, Wang M. Presumed asymptomatic carrier transmission of COVID-19. Jama. 2020;323(14):1406–07. doi:10.1056/NEJMoa2001316.
- Yashavantha Rao HC, Jayabaskaran C. The emergence of a novel coronavirus (SARS‐CoV‐2) disease and its neuroinvasive propensity may affect COVID‐19 patients. J Med Virol. 2020;92(7):786–90. doi:10.1002/jmv.25918.
- Alola AA, Alola UV, Sarkodie SA. The nCOVID-19 and financial stress in the USA: health is wealth. Environ Dev Sustain. 2021;23(6):9367–78. doi:10.1007/s10668-020-01029-w.
- Meludu NT, Abolade T. Corona Virus, Climate Change, and Food Security. In: Leal Filho W, Oguge N, Ayal D, Adeleke L, da Silva I, editors. African handbook of climate change adaptation 2021. Cham: Springer; 2021. p. 563–79. https://doi.org/10.1007/978-3-030-45106-6_233.
- United Nations (UN). Sustainable development outlook 2020: achieving SDGs in the wake of COVID-19: scenarios for policymakers. Department of Economic and Social Affairs Economic Analysis; 2020 [accessed 9 July 2021]. https://www.un.org/development/desa/dpad/publication/sustainable-development-outlook-2020-achieving-sdgs-in-the-wake-of-covid-19-scenarios-for-policymakers/.
- Sundararaman T, Muraleedharan VR, Ranjan A. Pandemic resilience and health systems preparedness: lessons from COVID-19 for the twenty-first century. J Social Econ Dev. 2021. doi:10.1007/s40847-020-00133-x.
- Alola AA, Olowu FB. The health scare of COVID-19 amidst pandemics and the immune-related pharmaceutical products spillovers in the USA. Environ Sci Pollut Res. 2020;27(36):45949–56. doi:10.1007/s11356-020-11195-z.
- Zimmer C, Corum J, Wee S, Times NY. Coronavirus Vaccine Tracker 2021. [accessed 9 July 2021]. https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html.
- Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New Eng J Med. 2020;383(27):2603–15. doi:10.1056/NEJMoa2034577.
- Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. New Eng J Med. 2021;384(5):403–16. https://doi/full/10.1056/nejmoa2035389.
- Voysey M, Clemens SA, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99–111. doi:10.1016/S0140-6736(20)32661-1.
- Velavan TP, Pollard AJ, Kremsner PG. Herd immunity and vaccination of children for COVID-19. Int J Infect Dis. 2020;98::14–15. doi:10.1016/j.ijid.2020.06.065.
- Felsenstein S, Hedrich CM. COVID-19 in children and young people. Lancet Rheumatol. 2020;2(9):e514–e516. doi:10.1016/S2665-9913(20)30212-5.
- Snape MD, Viner RM. COVID-19 in children and young people. Science. 2020;370(6514):286–88. doi:10.1126/science.abd6165.
- Reintjes R, Das E, Klemm C, Richardus JH, Keßler V, Ahmad A. Pandemic public health paradox”: time series analysis of the 2009/10 influenza A/H1N1 epidemiology, media attention, risk perception and public reactions in 5 European countries. PloS One. 2016;11(3):e0151258. doi:10.1371/journal.pone.0151258.
- Fadda M, Albanese E, Suggs LS. When a COVID-19 vaccine is ready, will we all be ready for it? Int J Public Health. 2020;65:711–12. doi:10.1007/s00038-020-01404-4.
- Larson H, de Figueiredo A, Karafillakis E, Rawal M. State of vaccine confidence in the EU 2018. Vol. 10. Luxembourg: Publications Office of the European Union; 2018. p. 241099. [accessed 21 February 2021]. https://www.quotidianosanita.it/allegati/allegato7138657.pdf.
- Kata A. Anti-vaccine activists, Web 2.0, and the postmodern paradigm–An overview of tactics and tropes used online by the anti-vaccination movement. Vaccine. 2012;30(25):3778–89. doi:10.1016/j.vaccine.2011.11.112.
- Business Standard. Bangladesh approves getting 30 mn doses of Covishield vaccine from India. 2021 [accessed 25 February 2021]. https://www.business-standard.com/article/current-affairs/bangladesh-approves-getting-30-mn-doses-of-covishield-vaccine-from-india-121010800256_1.html.
- Blankenship K. AstraZeneca hopes warmer storage needs for COVID-19 vaccine will be an advantage against mRNA competitors. FIERCE Pharma; 2020 [accessed 25 February 2021]. https://www.fiercepharma.com/manufacturing/astrazeneca-hopes-warmer-storage-needs-for-covid-19-vaccine-will-be-advantage-against
- Peretti-Watel P, Seror V, Cortaredona S, Launay O, Raude J, Verger P, Fressard L, Beck F, Legleye S, L’Haridon O, et al. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. Lancet Infect Dis. 2020;20(7):769–70. doi:10.1016/S1473-3099(20)30426-6.
- Khubchandani J, Sharma S, Price JH, Wiblishauser MJ, Sharma M, Webb FJ. COVID-19 vaccination hesitancy in the United States: a rapid national assessment. J Community Health. 2021;46(2):270–77. doi:10.1007/s10900-020-00958-x.
- Neumann-Böhme S, Varghese NE, Sabat I, Barros PP, Brouwer W, van Exel J, Schreyögg J, Stargardt T. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Health Econ. 2020;21(7):977–82. doi:10.1007/s10198-020-01208-6.
- Barello S, Nania T, Dellafiore F, Graffigna G, Caruso R. Vaccine hesitancy among university students in Italy during the COVID-19 pandemic. Eur J Epidemiol. 2020;35(8):781–83. doi:10.1007/s10654-020-00670-z.
- Thorneloe R, Wilcockson H, Lamb M, Jordan CH, Arden M. Willingness to receive a COVID-19 vaccine among adults at high-risk of COVID-19: a UK-wide survey. [accessed 5 March 2021]. https://psyarxiv.com/fs9wk/download?format=pdf.
- Paul A, Nath TK, Mahanta J, Sultana NN, Kayes AI, Noon SJ, Jabed MA, Podder S, Paul S. Psychological and livelihood impacts of COVID-19 on Bangladeshi lower income people. Asia Pac J Public Health. 2021;33(1):100–08. doi:10.1177/1010539520977304.
- Alola UV, Avci T, Ozturen A. Organization sustainability through human resource capital: the impacts of supervisor incivility and self-efficacy. Sustainability. 2018;10(8):2610. doi:10.3390/su10082610.
- Cop S, Alola UV, Alola AA. Perceived behavioral control as a mediator of hotels’ green training, environmental commitment, and organizational citizenship behavior: a sustainable environmental practice. Bus Strategy Environ. 2020;29(8):3495–508. doi:10.1002/bse.2592.
- Fontanet A, Cauchemez S. COVID-19 herd immunity: where are we? Nat Rev Immunol. 2020;20(10):583–84. doi:10.1038/s41577-020-00451-5.
- Jones D, Helmreich S. A history of herd immunity. Lancet. 2020;396(10254):810–11. doi:10.1016/S0140-6736(20)31924-3.
- Islam MS, Siddique AB, Akter R, Tasnim R, Sujan MS, Ward PR, Sikder MT. Knowledge, attitudes and perceptions towards COVID-19 vaccinations: a cross-sectional community survey in Bangladesh. medRxiv. 2021. doi:10.1101/2021.02.16.21251802.
- Banik R, Rahman M, Sikder MT, Rahman QM, Pranta MU. Knowledge, attitudes, and practices related to the COVID-19 pandemic among Bangladeshi youth: a web-based cross-sectional analysis. J Public Health (Bangkok). 2021;16:1–11. doi:10.1007/s10389-020-01432-7.
- Paul A, Sikdar D, Hossain MM, Amin MR, Deeba F, Mahanta J, Jabed MA, Islam MM, Noon SJ, Nath TK, et al. Knowledge, attitudes, and practices toward the novel coronavirus among Bangladeshis: implications for mitigation measures. PloS One. 2020;15(9):e0238492. doi:10.1371/journal.pone.0238492.
- Rafe R. COVID: bangladesh vaccination drive marred by misinformation. 2021 [accessed 23 March 2021]. https://www.dw.com/en/covid-bangladesh-vaccination-drive-marred-by-misinformation/a-56360529
- Jara T. Covid-19 vaccination in Bangladesh: we must report responsibly on vaccine side-effects. 2021 [accessed 23 March 2021]. https://www.thedailystar.net/opinion/news/we-must-report-responsibly-vaccine-side-effects-2042689.
- Chen M, Li Y, Chen J, Wen Z, Feng F, Zou H, Fu C, Chen L, Shu Y, Sun C. An online survey of the attitude and willingness of Chinese adults to receive COVID-19 vaccination. Hum Vaccin Immunother. 2021;17(7):2279–88. doi:10.1080/21645515.2020.1853449.
- Sherman SM, Smith LE, Sim J, Amlôt R, Cutts M, Dasch H, Rubin GJ, Sevdalis N. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccin Immunother. 2021;17(6):1612–21. doi:10.1080/21645515.2020.1846397.
- Chaudhary FA, Ahmad B, Khalid MD, Fazal A, Javaid MM, Butt DQ. Factors influencing COVID-19 vaccine hesitancy and acceptance among the Pakistani population. Hum Vaccin Immunother. 2021. doi:10.1080/21645515.2021.1944743.
- Shahid Z, Kalayanamitra R, McClafferty B, Kepko D, Ramgobin D, Patel R, Aggarwal CS, Vunnam R, Sahu N, Bhatt D, et al. COVID −19 and older adults: what we know. J Am Geriatr Soc. 2020;68(5):926–29. doi:10.1111/jgs.16472.
- Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–28. doi:10.1038/s41591-020-1124-9.
- Hasan K. Covid-19 vaccination: bangladesh on the right track. Dhaka Tribune; 2021 [accessed 23 March 2021]. https://www.dhakatribune.com/health/coronavirus/2021/02/14/covid-19-vaccination-bangladesh-on-the-right-track.
- Popa GL, Muntean AA, Muntean MM, Popa MI. Knowledge and attitudes on vaccination in Southern Romanians: a cross-sectional questionnaire. Vaccines. 2020;8(4):774. doi:10.3390/vaccines8040774.
- Jiang S. Don’t rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees. Nature. 2020:321–321. doi:10.1038/d41586-020-00751-9.
- Siciliani L, Wild C, McKee M, Kringos D, Barry MM, Barros PP, De Maeseneer J, Murauskiene L, Ricciardi W. Strengthening vaccination programmes and health systems in the European Union: a framework for action. Health Policy (New York). 2020;124(5):511–18. doi:10.1016/j.healthpol.2020.02.015.
- Nitschke JP, Forbes PA, Ali N, Cutler J, Apps MA, Lockwood PL, Lamm C. Resilience during uncertainty? Greater social connectedness during COVID‐19 lockdown is associated with reduced distress and fatigue. Br J Health Psychol. 2020. doi:10.1111/bjhp.12485.
- Miranda C, Silva V, Capita R, Alonso-Calleja C, Igrejas G, Poeta P. Implications of antibiotics use during the COVID-19 pandemic: present and future. J Antimicrob Chemother. 2020;75(12):3413–16. doi:10.1093/jac/dkaa350.
- Dhaka Tribune. Government to fix private vaccine price 2021 [accessed 24 March 2021]. https://www.dhakatribune.com/bangladesh/2021/01/18/health-minister-42-000-health-workers-being-provided-vaccination-training.
- Bdnews.com. Bangladesh’s Beximco could start private sales of AstraZeneca vaccine next month. 2021 [accessed 24 March 2021]. https://bdnews24.com/business/2021/01/12/bangladesh-s-beximco-could-start-private-sales-of-astrazeneca-vaccine-next-month.
- Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020;26:100495. doi:10.1016/j.eclinm.2020.100495.
- Reiter PL, Pennell ML, Katz ML. Acceptability of a COVID-19 vaccine among adults in the United States: how many people would get vaccinated? Vaccine. 2020;38(42):6500–07. doi:10.1016/j.vaccine.2020.08.043.
- Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, Setiawan AM, Rajamoorthy Y, Sofyan H, Mudatsir M, et al. Acceptance of a COVID-19 vaccine in southeast Asia: a cross-sectional study in Indonesia. Front Public Health. 2020;8. doi:10.3389/fpubh.2020.00381.
- Sarasty O, Carpio CE, Hudson D, Guerrero-Ochoa PA, Borja I. The demand for a COVID-19 vaccine in Ecuador. Vaccine. 2020;38(51):8090–98. doi:10.1016/j.vaccine.2020.11.013.
- Shammi M, Bodrud-Doza M, Islam AR, Rahman MM. COVID-19 pandemic, socio-economic crisis and human stress in resource-limited settings: a case from Bangladesh. Heliyon. 2020;6(5):e04063. doi:10.1016/j.heliyon.2020.e04063.
- MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–64. doi:10.1016/j.vaccine.2015.04.036.